Journal decision profile

BMC Molecular and Cell Biology

Biochemistry, Genetics and Molecular Biology · Medicine

BMC Molecular and Cell Biology's 2026 Journal Metrics Score is 2.1, ranking Q3 in Cancer Research and 2 other subfields. Two-year citation average from OpenAlex data, updated August 2026.

BioMed CentralUnited KingdomeISSN 2661-8850
Checking system sharing availability.Visit homepage

Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
2.1

Journal Metrics Score 2026 · 2021–2024 window citedness 3.20.

Submission-to-acceptance
i
Submission-to-acceptanceCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED
154 daysmedian

Middle 50%: 109–225 days

65 of 65 PubMed-indexed articles · 100% coverage · 2024–2025

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
$2,390

Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

Free preview · no sign-in

Does your manuscript fit BMC Molecular and Cell Biology?

Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.

Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iSubmission-to-acceptanceCalendar days from the received date to the accepted date in recent PubMed records. This includes editorial handling and author revisions, so it is not the time to first decision and not pure peer-review time. The radar uses a 0–100 cohort percentile with shorter observed timing plotted farther out; it does not measure review quality.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
2.12026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#598 / 1,263LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
10.9%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
0.77MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
154 daysIQR 109–225 DAYS
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
46 / yr2021–2024 AVG
Field-normalized top 10% share10.9%

20 of 184 works · same type, year & subfield

Field-normalized top 1% share0.5%

1 works · same type, year & subfield

Median FWCI0.77×

Below field-year expectation

Source output rank#598

of 1,263 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.77, so its typical recent paper runs about 23% below its field benchmark.

What does Top 10% Share mean?

10.9% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

02016
02017
02018
612019
902020
592021
612022
352023
292024
382025

Recent work-type mix

184 OpenAlex works · 2021–2024

Article95.7%
Erratum2.7%
Retraction1.1%
Review0.5%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

Select a MeSH signal to see how much BMC Molecular and Cell Biology publishes on it, from PubMed counts for the last five complete years.

Leading OpenAlex topics

2021–2024 works
Cancer-related molecular mechanisms research6
Genomics and Chromatin Dynamics6
Extracellular vesicles in disease4
MicroRNA in disease regulation4
Osteoarthritis Treatment and Mechanisms4
Protein Structure and Dynamics4
RNA Research and Splicing4
Asthma and respiratory diseases3
Bone Metabolism and Diseases3
Endometriosis Research and Treatment3
Methodology: OpenAlex snapshot 2026-10-27. FWCI, percentile badges, topics, and type mix use 184 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Cancer ResearchQ3
Cell BiologyQ3
Molecular BiologyQ3

Is BMC Molecular and Cell Biology a good journal?

A mid-ranked Q3 journal by citation data

By citation data, BMC Molecular and Cell Biology is a mid-ranked journal: it is Q3 in Cancer Research and 2 other subfields, the third quarter of journals by score, below the subfield median, and ranks #1,803 of 3,784 Biology & Basic Science journals by Journal Metrics Score (top 48%). BMC Molecular and Cell Biology's 2026 Journal Metrics Score is 2.1. Recent papers took a median of 154 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $2,390 USD. OpenAlex classifies its papers in subfields including Cancer Research, Cell Biology, and Molecular Biology, so check that your topic fits its scope.

Best quartile
Q3
Cancer Research
Rank in Biology & Basic Science
#1,803 of 3,784
Top 48%
2026 Journal Metrics Score
2.1
Acceptance rate
Not published
By the journal or publisher
Submission to acceptance
154 days
Median, PubMed records
Open access fee (APC)
$2,390
OpenAlex, verify with the journal
Papers published in 2025
38
OpenAlex works

Check before you submit

  • Confirm the current article processing charge, waivers, and any institutional agreement on the journal website; the OpenAlex figure is indicative.
  • Confirm the journal is indexed where your institution or funder requires (for example Scopus or PubMed) before you submit.

Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.

Q3
Subfield Quartile
B3
CAS Block

Ranking and source check

#1,803
of 3,784 Biology & Basic Science field journals
#32
among Q3 Biology & Basic Science journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

BMC journals compared

2026 Journal Metrics Scores for 13 of 52 BMC journals published by BioMed Central, highest score first. Each journal is scored separately; there is no combined score for the BMC family.

  1. BMC Medical Informatics and Decision Making6.1Q1
  2. BMC Biology5.8Q1
  3. BMC Biotechnology4.7Q1
  4. BMC Bioinformatics4.6Q2
  5. BMC Plant Biology4.6Q1
  6. BMC Genomics4.2Q1
  7. BMC Microbiology4.0Q1
  8. BMC Cancer3.7Q1
  9. BMC Pharmacology & Toxicology3.1Q1
  10. BMC Ecology and Evolution3.0Q1
  11. BMC Medical Genomics3.0Q1
  12. BMC Genomic Data2.2Q2
  13. BMC Molecular and Cell Biologythis journal2.1Q3

Journal Details

OpenAlex Works
409
H-Index
33
Fully Open Access
Yes
Recent OA Works
408
Subject Areas
Cancer ResearchCell BiologyMolecular Biology

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

How to submit to BMC Molecular and Cell Biology

  1. 1

    Check the scope

    OpenAlex classifies BMC Molecular and Cell Biology's papers in subfields including Cancer Research, Cell Biology, and Molecular Biology. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.

  2. 2

    Follow the author guidelines

    Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.

    BMC Molecular and Cell Biology homepage ↗
  3. 3

    Submit online

    Use the submit link in BMC Molecular and Cell Biology's author guidelines; BioMed Central runs the submission site. Every author usually needs an ORCID iD, and the corresponding author needs an account on the submission site.

  4. 4

    Plan for costs

    OpenAlex lists an indicative article processing charge of $2,390 USD for this open-access journal. Check the current fee, waivers, and any institutional agreement on the journal website.

  5. 5

    Know what to expect

    Recent accepted papers took a median of 154 days from submission to acceptance, including revisions (PubMed dates). BMC Molecular and Cell Biology does not publish an acceptance rate.

New on PubMed

What's new in your field?

Type a topic to see the newest PubMed papers from the past week and the big picture of what they found, summarized by Claude on the Pro plan. Get a free weekly email to keep up.

See a demo:GLP-1CRISPRLong COVID

Reviewer Two · coming soon

Know what reviewers will say before you submit to BMC Molecular and Cell Biology

An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.

See what the report covers

Common questions about BMC Molecular and Cell Biology

Is BMC Molecular and Cell Biology a good journal?

By citation data, BMC Molecular and Cell Biology is a mid-ranked journal: it is Q3 in Cancer Research and 2 other subfields, the third quarter of journals by score, below the subfield median, and ranks #1,803 of 3,784 Biology & Basic Science journals by Journal Metrics Score (top 48%). BMC Molecular and Cell Biology's 2026 Journal Metrics Score is 2.1. Recent papers took a median of 154 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $2,390 USD. OpenAlex classifies its papers in subfields including Cancer Research, Cell Biology, and Molecular Biology, so check that your topic fits its scope.

What is BMC Molecular and Cell Biology's Journal Metrics Score in 2026?

BMC Molecular and Cell Biology's 2026 Journal Metrics Score is 2.1, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.

What is the acceptance rate of BMC Molecular and Cell Biology?

We have not found an official acceptance rate published by BMC Molecular and Cell Biology or its publisher, and Journal Metrics does not estimate one because submission counts are not public. What recent PubMed records do show is speed: accepted papers took a median of 154 days from submission to acceptance. To judge selectivity, compare BMC Molecular and Cell Biology's quartile and score with similar journals, or ask the editorial office.

What quartile is BMC Molecular and Cell Biology in?

BMC Molecular and Cell Biology's best quartile is Q3. By OpenAlex subfield: Q3 in Cancer Research; Q3 in Cell Biology; Q3 in Molecular Biology. Quartiles rank journals by Journal Metrics Score within each subfield.

Is the Journal Metrics Score the same as other journal citation metrics?

No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for BMC Molecular and Cell Biology will not match this score exactly. Compare journals using one source at a time.

How long does BMC Molecular and Cell Biology take from submission to acceptance?

Across 65 recent PubMed records with both dates, BMC Molecular and Cell Biology took a median of 154 days from submission to acceptance; the middle half took 109–225 days. This interval includes editorial handling and revisions, so it is not the time to a first decision.

How much does it cost to publish in BMC Molecular and Cell Biology?

OpenAlex lists an indicative article processing charge of $2,390 USD for BMC Molecular and Cell Biology. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.

Which journals are alternatives to BMC Molecular and Cell Biology?

Comparable journals include Cellular & Molecular Biology Letters, International Journal of Oncology, Cell Death Discovery, and International Journal of Biological Sciences. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.

How do I submit a paper to BMC Molecular and Cell Biology?

Submit online through the link in BMC Molecular and Cell Biology's author guidelines on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter. Accepted papers took a median of 154 days from submission to acceptance in recent PubMed records.

Cite an article from this journal
Back to Search